Breaking Barriers in Digital Accessibility
In 1989, a groundbreaking tool emerged that would significantly enhance digital accessibility for individuals who are blind or have low vision. JAWS (Job Access With Speech), developed by Freedom Scientific, has since become a pivotal tool in the realm of assistive technology.
The Journey Begins
JAWS was first introduced by Henter-Joyce, a company founded by Ted Henter, a visionary who himself was blind. It was among the first screen readers to provide speech output for Windows applications, marking a significant leap forward in technology accessibility.
Growth and Innovation
After its acquisition by Freedom Scientific in 2000, JAWS has seen continuous development, incorporating new features and improving compatibility with various applications and operating systems. Innovations such as support for web browsing, document reading, and the JAWS Picture Smart AI for detailed image descriptions have set new standards in assistive technology.
Empowering Lives
JAWS has empowered countless individuals with visual impairments, enabling them to participate more fully in education, employment, and daily life. Its adoption in educational settings and workplaces underscores its essential role in promoting inclusivity and independence.
A Community of Support
The success of JAWS has fostered a community of users and advocates for accessibility, leading to increased awareness and support for accessibility initiatives.
As we celebrate the 30th anniversary of JAWS, let’s reflect on its monumental impact and the doors it has opened for individuals around the world. It’s more than just software; it’s a testament to the power of technology to transform lives.
To all those who have been part of this journey, your stories and experiences are what truly highlight the significance of JAWS. Here’s to many more years of innovation and empowerment.

More Articles
Article title: World Diabetes Day – 14 November 2020 .
SCREEN FOR VISION - SCREEN FOR LIFE The eye is said to be the window to the soul. Those of.
Article title: Tribute to James Cape .
Retina South Africa sadly announces the passing of our Chairman James Cape in July 2021. James was Chairman of.
Article title: Stellar RNA Trial for Stargardt Disease .
The STELLAR clinical trial is a research study of a potential new treatment for people with ABCA4 retinopathy –.